Given that AMPK remains genetically intact in almost all cases of tumourigenesis (∼ 99% of human tumours, Fig. S1A), it is reasonable that mTOR activation requires loss of AMPK positive regulators such as LKB1. The gene discussed is STK11; the disease is neoplasm.